GANA V

The benefits of GANA V are:
- Stimulates collagen production.
- Restores volume and shape to the face.
- Visible results over time, with complete absorption within about 2 years.
- It reduces skin sagging and signs of ageing without immediate filler.
- Customisable treatment.

- GANA R&D CO., LTD.
- NAME: GANA V
- COMPOSITION: Poly-L-lactic acid 210 mg, CMC (carboxymethylcellulose sodium), Mannitol (medical grade).
- PRESENTATION: 1 x 210mg/15 ml.
- INDICATIONS: Indicated for correction of skin depressions such as wrinkles and furrows.
- APPLICATION: Deep dermis or subcutaneous layer.
- DURATION: It is suggested that the second session be performed 30 days after the first, while the third session should be performed 30 days after the second.
The minimum frequency between application sessions is 1 month. After the third session, the minimum recommended frequency for subsequent treatments is between 6 and 12 months. Three or more sessions are permitted, depending on the doctor's assessment and judgement.
- USE: Strict medical use.

- Vial: 1 x 210mg/15 ml.

Temporal area. nasolabial folds, zygomatic area and cheeks.

Poly-L-lactic acid 210 mg, CMC (sodium carboxymethyl cellulose), Mannitol (medical grade).

- This product should only be used by a doctor who is fully familiar with the product, the information material and the entire patient information leaflet and labelling.
- The treatment area must be disinfected with an antiseptic and must not be inflamed or infected.
- As with all injections, patients with coagulation disorders or on anticoagulant therapy have an increased risk of bruising, ecchymosis and/or bleeding at the injection site.
- The safety and efficacy of the product have not been evaluated in patients who are pregnant, lactating or under 18 years of age.
- No interaction studies of this product with drugs, other substances or implants have been conducted.
- An increased risk of papules and nodules after injections in the periorbital area has been reported in the literature.
- The safety and efficacy of the product have not been evaluated in patients with a tendency to form keloids or hypertrophic scars. Therefore, it should not be used in patients with a known history or predisposition to keloid or hypertrophic scar formation.
- The patient should be instructed to limit exposure of the treated area to the sun and avoid exposure to UV lamps until any initial oedema and redness has completely disappeared.

- This product must not be used in persons with active inflammation or infection in or near the treatment area.
- This product must not be used in persons with hypersensitivity to any of its components.
- Do not use in or near the periorbital area and lips.
- Do not use around the eyes.

The device is indicated for increasing the volume of depressed areas and for major volumetric corrections in the facial region.